FTDP-17 missense mutations site-specifically inhibit as well as promote dephosphorylation of microtubule-associated protein tau by protein phosphatases of HEK-293 cell extract

Neurochemistry International

Volumn 54, Issue 1, 2009, Pages 14-27

  Han, Dong ^a,b   Paudel, Hemant K ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

FTDP 17; Microtubule associated protein tau; Protein phosphatase 1; Protein phosphatase 2A; Protein phosphatase 2B; Tau protein dephosphorylation

Indexed keywords

CALCINEURIN; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; SERINE; TAU PROTEIN; THREONINE;

ARTICLE; ASSAY; BRAIN; CELL LYSATE; CELL STRAIN HEK293; CHROMOSOME; CYTOLYSIS; EMBRYO; FRONTOTEMPORAL DEMENTIA AND PARKINSONISM LINKED TO CHROMOSOME 17; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INCUBATION TIME; MISSENSE MUTATION; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION;

AMINO ACIDS; ANTIBODIES, MONOCLONAL; BRAIN; CELL LINE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; HUMANS; KIDNEY; MUTATION, MISSENSE; NERVE TISSUE PROTEINS; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; RECOMBINANT PROTEINS; TAU PROTEINS; TRANSFECTION;

MUS MUSCULUS;

EID: 59049104019     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2008.09.014     Document Type: Article

References (63)

1. Adamec E., Murrell J.R., Takao M., Hobbs W., Nixon R.A., Ghetti B., and Vonsattel J.P. P301L tauopathy: confocal immunofluorescence study of perinuclear aggregation of the mutated protein. J. Neurol. Sci. 200 (2002) 85-93
2. Agarwal-Mawal A., and Paudel H.K. Neuronal Cdc2-like protein kinase (Cdk5/p25) is associated with protein phosphatase 1 and phosphorylates inhibitor-2. J. Biol. Chem. 276 (2001) 23712-23718
3. Alonso Adel C., Mederlyova A., Novak M., Grundke-Iqbal I., and Iqbal K. Promotion of hyperphosphorylation by frontotemporal dementia tau mutations. J. Biol. Chem. 279 (2004) 34873-34881
4. Bialojan C., and Takai A. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem. J. 256 (1988) 283-290
5. Bronner I.F., ter Meulen B.C., Azmani A., Severijnen L.A., Willemsen R., Kamphorst W., Ravid R., Heutink P., and van Swieten J.C. Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology. Brain 128 (2005) 2645-2653
6. Cohen P. The structure and regulation of protein phosphatases. Annu. Rev. Biochem. 58 (1989) 453-508
7. Connell J.W., Gibb G.M., Betts J.C., Blackstock W.P., Gallo J., Lovestone S., Hutton M., and Anderton B.H. Effects of FTDP-17 mutations on the in vitro phosphorylation of tau by glycogen synthase kinase 3beta identified by mass spectrometry demonstrate certain mutations exert long-range conformational changes. FEBS Lett. 493 (2001) 40-44
8. Crowther R.A., and Goedert M. Abnormal tau-containing filaments in neurodegenerative diseases. J. Struct. Biol. 130 (2000) 271-279
9. Dou F., Netzer W.J., Tanemura K., Li F., Hartl F.U., Takashima A., Gouras G.K., Greengard P., and Xu H. Chaperones increase association of tau protein with microtubules. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 721-726
10. Drewes G., Mandelkow E.M., Baumann K., Goris J., Merlevede W., and Mandelkow E. Dephosphorylation of tau protein and Alzheimer paired helical filaments by calcineurin and phosphatase-2A. FEBS Lett. 336 (1993) 425-432
11. Enan E., and Matsumura F. Specific inhibition of calcineurin by type II synthetic pyrethroid insecticides. Biochem. Pharmacol. 43 (1992) 1777-1784
12. Galas M.C., Dourlen P., Begard S., Ando K., Blum D., Hamdane M., and Buee L. The peptidylprolyl cis/trans-isomerase Pin1 modulates stress-induced dephosphorylation of Tau in neurons. Implication in a pathological mechanism related to Alzheimer disease. J. Biol. Chem. 281 (2006) 19296-19304
13. Goedert M., Jakes R., Qi Z., Wang J.H., and Cohen P. Protein phosphatase 2A is the major enzyme in brain that dephosphorylates tau protein phosphorylated by proline-directed protein kinases or cyclic AMP-dependent protein kinase. J. Neurochem. 65 (1995) 2804-2807
14. Goedert M., Satumtira S., Jakes R., Smith M.J., Kamibayashi C., White III C.L., and Sontag E. Reduced binding of protein phosphatase 2A to tau protein with frontotemporal dementia and parkinsonism linked to chromosome 17 mutations. J. Neurochem. 75 (2000) 2155-2162
15. Gong C.X., Lidsky T., Wegiel J., Zuck L., Grundke-Iqbal I., and Iqbal K. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J. Biol. Chem. 275 (2000) 5535-5544
16. Gooch J.L. An emerging role for calcineurin Aalpha in the development and function of the kidney. Am. J. Physiol. Renal Physiol. 290 (2006) F769-776
17. Gotz J., Chen F., Barmettler R., and Nitsch R.M. Tau filament formation in transgenic mice expressing P301L tau. J. Biol. Chem. 276 (2001) 529-534
18. Gotz J., Chen F., van Dorpe J., and Nitsch R.M. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 293 (2001) 1491-1495
19. Gotz J., Tolnay M., Barmettler R., Chen F., Probst A., and Nitsch R.M. Oligodendroglial tau filament formation in transgenic mice expressing G272V tau. Eur. J. Neurosci. 13 (2001) 2131-2140
20. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., and Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 4913-4917
21. Hashiguchi M., Sobue K., and Paudel H.K. 14-3-3zeta is an effector of tau protein phosphorylation. J. Biol. Chem. 275 (2000) 25247-25254
22. Hong M., Zhukareva V., Vogelsberg-Ragaglia V., Wszolek Z., Reed L., Miller B.I., Geschwind D.H., Bird T.D., McKeel D., Goate A., Morris J.C., Wilhelmsen K.C., Schellenberg G.D., Trojanowski J.Q., and Lee V.M. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282 (1998) 1914-1917
23. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R.C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J.M., Nowotny P., Che L.K., Norton J., Morris J.C., Reed L.A., Trojanowski J., Basun H., Lannfelt L., Neystat M., Fahn S., Dark F., Tannenberg T., Dodd P.R., Hayward N., Kwok J.B., Schofield P.R., Andreadis A., Snowden J., Craufurd D., Neary D., Owen F., Oostra B.A., Hardy J., Goate A., van Swieten J., Mann D., Lynch T., and Heutink P. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393 (1998) 702-705
24. Iqbal K., Grundke-Iqbal I., Zaidi T., Merz P.A., Wen G.Y., Shaikh S.S., Wisniewski H.M., Alafuzoff I., and Winblad B. Defective brain microtubule assembly in Alzheimer's disease. Lancet 2 (1986) 421-426
25. Jensen P.H., Hager H., Nielsen M.S., Hojrup P., Gliemann J., and Jakes R. Alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356. J. Biol. Chem. 274 (1999) 25481-25489
26. Kidd M. Paired helical filaments in electron microscopy of Alzheimer's disease. Nature 197 (1963) 192-193
27. Kins S., Crameri A., Evans D.R., Hemmings B.A., Nitsch R.M., and Gotz J. Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice. J. Biol. Chem. 276 (2001) 38193-38200
28. Krishnamurthy P.K., and Johnson G.V. Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model. J. Biol. Chem. 279 (2004) 7893-7900
29. Lee V.M., Goedert M., and Trojanowski J.Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24 (2001) 1121-1159
30. Lee V.M., Balin B.J., Otvos Jr. L., and Trojanowski J.Q. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 251 (1991) 675-678
31. Lewis J., McGowan E., Rockwood J., Melrose H., Nacharaju P., Van Slegtenhorst M., Gwinn-Hardy K., Paul Murphy M., Baker M., Yu X., Duff K., Hardy J., Corral A., Lin W.L., Yen S.H., Dickson D.W., Davies P., and Hutton M. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 25 (2000) 402-405
32. Li T., and Paudel H.K. Glycogen synthase kinase 3beta phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism. Biochemistry 45 (2006) 3125-3133
33. Li T., Chalifour L.E., and Paudel H.K. Phosphorylation of protein phosphatase 1 by cyclin-dependent protein kinase 5 during nerve growth factor-induced PC12 cell differentiation. J. Biol. Chem. 282 (2007) 6619-6628
34. Liou Y.C., Sun A., Ryo A., Zhou X.Z., Yu Z.X., Huang H.K., Uchida T., Bronson R., Bing G., Li X., Hunter T., and Lu K.P. Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature 424 (2003) 556-561
35. Liu F., Grundke-Iqbal I., Iqbal K., and Gong C.X. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur. J. Neurosci. 22 (2005) 1942-1950
36. Mack T.G., Dayanandan R., Van Slegtenhorst M., Whone A., Hutton M., Lovestone S., and Anderton B.H. Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation profiles in differentiated neuroblastoma cells. Neuroscience 108 (2001) 701-712
37. Matsumura N., Yamazaki T., and Ihara Y. Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Am. J. Pathol. 154 (1999) 1649-1656
38. Mawal-Dewan M., Henley J., Van de Voorde A., Trojanowski J.Q., and Lee V.M. The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases. J. Biol. Chem. 269 (1994) 30981-30987
39. Merrick S.E., Trojanowski J.Q., and Lee V.M. Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons. J. Neurosci. 17 (1997) 5726-5737
40. Mumby M.C., and Walter G. Protein serine/threonine phosphatases: structure, regulation, and functions in cell growth. Physiol. Rev. 73 (1993) 673-699
41. Oliver C.J., and Shenolikar S. Physiologic importance of protein phosphatase inhibitors. Front. Biosci. 3 (1998) D961-972
42. Ono T., Yamamoto H., Tashima K., Nakashima H., Okumura E., Yamada K., Hisanaga S., Kishimoto T., Miyakawa T., and Miyamoto E. Dephosphorylation of abnormal sites of tau factor by protein phosphatases and its implication for Alzheimer's disease. Neurochem. Int. 26 (1995) 205-215
43. Perez M., Lim F., Arrasate M., and Avila J. The FTDP-17-linked mutation R406W abolishes the interaction of phosphorylated tau with microtubules. J. Neurochem. 74 (2000) 2583-2589
44. Planel E., Yasutake K., Fujita S.C., and Ishiguro K. Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse. J. Biol. Chem. 276 (2001) 34298-34306
45. Poorkaj P., Bird T.D., Wijsman E., Nemens E., Garruto R.M., Anderson L., Andreadis A., Wiederholt W.C., Raskind M., and Schellenberg G.D. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43 (1998) 815-825
46. Reed L.A., Grabowski T.J., Schmidt M.L., Morris J.C., Goate A., Solodkin A., Van Hoesen G.W., Schelper R.L., Talbot C.J., Wragg M.A., and Trojanowski J.Q. Autosomal dominant dementia with widespread neurofibrillary tangles. Ann. Neurol. 42 (1997) 564-572
47. Sahara N., Tomiyama T., and Mori H. Missense point mutations of tau to segregate with FTDP-17 exhibit site-specific effects on microtubule structure in COS cells: a novel action of R406W mutation. J. Neurosci. Res. 60 (2000) 380-387
48. Sakaue F., Saito T., Sato Y., Asada A., Ishiguro K., Hasegawa M., and Hisanaga S. Phosphorylation of FTDP-17 mutant tau by cyclin-dependent kinase 5 complexed with p35, p25, or p39. J. Biol. Chem. 280 (2005) 31522-31529
49. Sistiaga A., and Sanchez-Prieto J. Protein phosphatase 1 and 2A inhibitors prolong the switch in the control of glutamate release by group I metabotropic glutamate receptors: characterization of the inhibitory pathway. J. Neurochem. 75 (2000) 1566-1574
50. Sobue K., Agarwal-Mawal A., Li W., Sun W., Miura Y., and Paudel H.K. Interaction of neuronal Cdc2-like protein kinase with microtubule-associated protein tau. J. Biol. Chem. 275 (2000) 16673-16680
51. Sontag E., Nunbhakdi-Craig V., Lee G., Bloom G.S., and Mumby M.C. Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A. Neuron 17 (1996) 1201-1207
52. Spillantini M.G., Crowther R.A., and Goedert M. Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles. Acta Neuropathol. 92 (1996) 42-48
53. Spillantini M.G., Crowther R.A., Kamphorst W., Heutink P., and van Swieten J.C. Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau. Am. J. Pathol. 153 (1998) 1359-1363
54. Spillantini M.G., Murrell J.R., Goedert M., Farlow M.R., Klug A., and Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 7737-7741
55. Sun L., Liu S.Y., Zhou X.W., Wang X.C., Liu R., Wang Q., and Wang J.Z. Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats. Neuroscience 118 (2003) 1175-1182
56. Tanemura K., Murayama M., Akagi T., Hashikawa T., Tominaga T., Ichikawa M., Yamaguchi H., and Takashima A. Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau. J. Neurosci. 22 (2002) 133-141
57. Tatebayashi Y., Miyasaka T., Chui D.H., Akagi T., Mishima K., Iwasaki K., Fujiwara M., Tanemura K., Murayama M., Ishiguro K., Planel E., Sato S., Hashikawa T., and Takashima A. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 13896-13901
58. van Swieten J.C., Stevens M., Rosso S.M., Rizzu P., Joosse M., de Koning I., Kamphorst W., Ravid R., Spillantini M.G., Niermeijer, and Heutink P. Phenotypic variation in hereditary frontotemporal dementia with tau mutations. Ann. Neurol. 46 (1999) 617-626
59. Vogelsberg-Ragaglia V., Bruce J., Richter-Landsberg C., Zhang B., Hong M., Trojanowski J.Q., and Lee V.M. Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells. Mol. Biol. Cell 11 (2000) 4093-4104
60. Wang J.Z., Grundke-Iqbal I., and Iqbal K. Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, -2B and -1. Brain Res. Mol. Brain Res. 38 (1996) 200-208
61. Wang J.Z., Gong C.X., Zaidi T., Grundke-Iqbal I., and Iqbal K. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. J. Biol. Chem. 270 (1995) 4854-4860
62. Yamamoto H., Hasegawa M., Ono T., Tashima K., Ihara Y., and Miyamoto E. Dephosphorylation of fetal-tau and paired helical filaments-tau by protein phosphatases 1 and 2A and calcineurin. J. Biochem. 118 (1995) 1224-1231
63. Yoshiyama Y., Higuchi M., Zhang B., Huang S.M., Iwata N., Saido T.C., Maeda J., Suhara T., Trojanowski J.Q., and Lee V.M. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53 (2007) 337-351